Richard L Edelson from 76 Coleytown Rd, Westport, CT 06880, age 79, Phone: 203 454-8666

Medicine Doctors

Dr. Richard L Edelson, New Haven CT - MD (Doctor of Medicine)

view source

Specialties:

Dermatology

Address:

333 Cedar St Suite Lc1501, New Haven, CT 06510

15 York St, New Haven, CT 06510
203 785-4632 (Phone), 203 785-3315 (Fax)

YALE DERMATOLOGY ASSOCIATES
2 Church St S Suite 305, New Haven, CT 06519
203 789-1249 (Phone), 203 776-6188 (Fax)

YALE NEW HAVEN HOSPITAL PEDIATRIC HEMATOLOGY ONCOLOGY
333 Cedar St, New Haven, CT 06510
203 785-4640 (Phone), 203 737-2228 (Fax)

Certifications:

Dermatology, 1977

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

333 Cedar St Suite Lc1501, New Haven, CT 06510

15 York St, New Haven, CT 06510

YALE DERMATOLOGY ASSOCIATES
2 Church St S Suite 305, New Haven, CT 06519

YALE NEW HAVEN HOSPITAL PEDIATRIC HEMATOLOGY ONCOLOGY
333 Cedar St, New Haven, CT 06510

Yale - New Haven Hospital
20 York Street, New Haven, CT 06510

Education:

Medical School
Yale University
Graduated: 1970
Medical School
U Chicago Hosp-Clins
Graduated: 1970
Medical School
Massachusetts General Hospital
Graduated: 1970
Medical School
Nih-Presby Hosp
Graduated: 1970
Medical School
National Institute Of Allergy and Infectious Disease
Graduated: 1975

Dr. Richard N Edelson, Silver Spring MD - MD (Doctor of Medicine)

view source

Specialties:

Neuropsychiatry (Neurology)

Address:

7987 Georgia Ave, Silver Spring, MD 20910
301 557-1870 (Phone), 301 557-1879 (Fax)

5454 Wisconsin Ave Suite 1750, Chevy Chase, MD 20815
301 652-3040 (Phone)

Certifications:

Neurology, 1975

Awards:

Healthgrades Honor Roll

Languages:

English

Education:

Medical School
Harvard Medical School
Graduated: 1966
Medical School
Presby-St Lukes Hosp
Graduated: 1966
Medical School
New York Presbyterian Hospital-New York Weill Cornell Center
Graduated: 1966

Dr. Richard C Edelson, New Haven CT - DC (Doctor of Chiropractic)

view source

Specialties:

Chiropractic

Address:

Yale Dermatology Associates
2 Church St S Suite 305, New Haven, CT 06519
203 789-1249 (Phone)

Languages:

English

Richard H. Edelson

view source

Specialties:

Orthopaedic Surgery, Orthopedic Sports Medicine

Work:

Sports Medicine Oregon
7300 SW Childs Rd STE B, Portland, OR 97224
503 692-8700 (phone), 503 692-8710 (fax)

Education:

Medical School
Oregon Health & Science University School of Medicine
Graduated: 1987

Procedures:

Arthrocentesis
Knee Arthroscopy
Shoulder Arthroscopy
Shoulder Surgery

Conditions:

Ankylosing Spondylitis (AS)
Fractures, Dislocations, Derangement, and Sprains
Internal Derangement of Knee
Internal Derangement of Knee Cartilage
Internal Derangement of Knee Ligaments

Languages:

English

Description:

Dr. Edelson graduated from the Oregon Health & Science University School of Medicine in 1987. He works in Tigard, OR and specializes in Orthopaedic Surgery and Orthopedic Sports Medicine. Dr. Edelson is affiliated with Legacy Meridian Park Hospital, PeaceHealth Southwest Medical Center, Providence Saint Vincent Medical Center and Providence Willamette Falls Medical Center.

Richard L. Edelson

view source

Specialties:

Dermatology

Work:

Yale Medical GroupYale Dermatology Associates
2 Church St S STE 305, New Haven, CT 06519
203 789-1249 (phone)

Education:

Medical School
Yale University School of Medicine
Graduated: 1970

Procedures:

Destruction of Benign/Premalignant Skin Lesions
Skin Surgery

Conditions:

Dermatitis
Skin Cancer
Acne
Alopecia Areata
Atopic Dermatitis

Languages:

English
Spanish

Description:

Dr. Edelson graduated from the Yale University School of Medicine in 1970. He works in New Haven, CT and specializes in Dermatology. Dr. Edelson is affiliated with Yale New Haven Hospital.

Richard A. Edelson

view source

Specialties:

Cardiovascular Disease

Work:

Palmetto Heart
300 Palmetto Health Pkwy STE 400, Columbia, SC 29212
803 434-3800 (phone), 803 744-2759 (fax)

Palmetto Heart
8 Medical Park Dr, Columbia, SC 29203
803 434-3800 (phone), 803 744-2741 (fax)

Education:

Medical School
Virginia Commonwealth University SOM
Graduated: 1991

Procedures:

Cardiac Stress Test
Cardioversion
Cardiac Catheterization
Continuous EKG
Echocardiogram
Electrocardiogram (EKG or ECG)
Pacemaker and Defibrillator Procedures

Conditions:

Acute Myocardial Infarction (AMI)
Angina Pectoris
Aortic Valvular Disease
Atherosclerosis
Atrial Fibrillation and Atrial Flutter

Languages:

English
Spanish

Description:

Dr. Edelson graduated from the Virginia Commonwealth University SOM in 1991. He works in Columbia, SC and 1 other location and specializes in Cardiovascular Disease. Dr. Edelson is affiliated with Palmetto Health Baptist, Palmetto Health Baptist Parkridge and Palmetto Health Richland Hospital.

Richard I. Edelson

view source

Specialties:

Neurology, Psychologist

Work:

Edelson & Associates
7511 New Ln Grange Rd, Louisville, KY 40222
502 423-1151 (phone), 502 423-1748 (fax)

Languages:

English

Description:

Dr. Edelson works in Louisville, KY and specializes in Neurology and Psychologist. Dr. Edelson is affiliated with Baptist Health Louisville, Jewish Hospital and Norton Hospital.

Richard N Edelson, Silver Spring MD

view source

Specialties:

Neurology
Neurological Surgery
Psychiatry
Vascular Surgery

Work:

Holy Cross Health Center Silver Spring
7987 Georgia Ave, Silver Spring, MD 20910

Education:

Harvard University(1966)

Wikipedia References

Richard Edelson

Name / Title

Company / Classification

Phones & Addresses

Richard L. Edelson
Medical Doctor

Yale-New Haven Hospital, Inc
General Hospital Medical Doctor's Office · Medical Doctor's Office

333 Cedar St, New Haven, CT 06510
203 785-2564

Richard Edelson
Chief Financial Officer, Officer/executive

Centrecourt Asset Management LLC
Investment Advice

11 E 44 St, New York, NY 10017
350 Madison Ave, New York, NY 10017
646 758-6750

Richard Leslie Edelson

Edelson, Dr. Richard
Dermatologist

2 Church St S, New Haven, CT 06519
203 789-1249

Richard L. Edelson
Dermatology

Dermatology Associates, PC
Medical Doctor's Office

2 Church St S, New Haven, CT 06519
203 787-4171

Richard L. Edelson
Chair Of Cancer Committee

Yale-New Haven Hospital
Hospital & Health Care · General Hospital Child Day Care Services · General Hospital Specialty Hospital · Specialty Hospital · Dermatologist · Ophthalmology · Colon Care · Surgeons

20 York St, New Haven, CT 06510
20 York St Rm Cb30, New Haven, CT 06510
15 York St, New Haven, CT 06510
203 688-4242, 203 688-2433, 203 453-7123, 203 785-3575

Richard Edelson
Owner

Windows Windows Incorporated
Whol Lumber/Plywood/Millwork

5 Rockland Pl, Greenwich, CT 06831

Richard L. Edelson
Principal

Transimmune
Business Services at Non-Commercial Site

76 Coleytown Rd, Westport, CT 06880

Resumes

Professor

view source

Location:

76 Coleytown Rd, Westport, CT 06880

Industry:

Biotechnology

Work:

Yale University School of Medicine
Professor

Education:

Yale University School of Medicine 1966 - 1970

Professor

view source

Location:

Westport, CT

Work:

Yale University
Professor

Richard Edelson

view source

Us Patents

Specific Immune System Modulation
view source
US Patent:

6355238, Mar 12, 2002
Filed:

Mar 21, 1997
Appl. No.:

08/822940
Inventors:

Richard L. Edelson - Westport CT
Francis P. Gasparro - Hamden CT
Robert E. Tigelaar - Guilford CT
Assignee:

Yale University - New Haven CT
International Classification:

A01N 6300
US Classification:

424 931, 435325, 530300
Abstract:

Methods and pharmaceutical compositions for modifying the immune response of a mammal to a specific antigen are provided. The methods include treating an antigen presenting cell to enhance expression of a major histocompatibility complex molecule and reacting the treated antigen presenting cell with the antigen extracorporeally to form an antigen-associated antigen presenting cell.

Methods For Inducing The Differentiation Of Monocytes Into Functional Dendritic Cells
view source
US Patent:

6524855, Feb 25, 2003
Filed:

Aug 13, 2001
Appl. No.:

09/928811
Inventors:

Richard Leslie Edelson - Westport CT 06880
Carole Berger - Riverdale, Bronx NY 10471
International Classification:

C12N 500
US Classification:

435377, 435 2, 435325, 435347, 435355, 435372
Abstract:

A method for inducing differentiation of monocytes contained in an extracorporeal quantity of a subjects blood into functional dendritic antigen presenting cells is provided. The monocytes are first treated by exposure to physical perturbation, irradiation in the presence of a photoactivatable agent capable of forming photoadducts with cellular DNA components, and/or treatment with a DNA binding agent. The treated monocytes are then incubated for a period of time sufficient to maximize the number of functional dendritic cells in the treated cell population. Functional dendritic cells generated from induced monocytes are incubated together with disease effector agents to enhance the presentation of at least one disease-causing antigen expressed by the disease effector agents.

Methods For Inducing The Differentiation Of Monocytes Into Functional Dendritic Cells
view source
US Patent:

6607722, Aug 19, 2003
Filed:

Aug 13, 2001
Appl. No.:

09/928855
Inventors:

Richard Leslie Edelson - Westport CT 06880
Carole Berger - Riverdale, Bronx NY 10471
International Classification:

A01N 6300
US Classification:

424 937, 424 931, 435377, 435 2, 435325
Abstract:

A method for inducing differentiation of monocytes contained in an extracorporeal quantity of a subjects blood into functional dendritic antigen presenting cells is provided. The monocytes are first treated by exposure to physical perturbation, irradiation in the presence of a photoactivatable agent capable of forming photoadducts with cellular DNA components, and/or treatment with a DNA binding agent. The treated monocytes are then incubated for a period of time sufficient to maximize the number of functional dendritic cells in the treated cell population. Functional dendritic cells generated from induced monocytes are incubated together with disease effector agents to enhance the presentation of at least one disease-causing antigen expressed by the disease effector agents.

Methods For Inducing The Differentiation Of Monocytes Into Functional Dendritic Cells And Immunotherapeutic Compositions Including Such Dendritic Cells
view source
US Patent:

7109031, Sep 19, 2006
Filed:

Mar 13, 2003
Appl. No.:

10/388716
Inventors:

Richard Leslie Edelson - Westport CT, US
Carole Berger - Bronx NY, US
Douglas Hanlon - Branford CT, US
Michael Girardi - Madison CT, US
Assignee:

Yale University - New Haven CT
International Classification:

C12N 5/00
US Classification:

435377, 435366, 435325, 604 401, 604 501
Abstract:

A method for inducing differentiation of monocytes contained in an extracorporeal quantity of a subject's blood into functional dendritic antigen presenting cells is provided. The monocytes are induced to differentiate into dendritic cells by activation forces resulting from flow of the monocytes through a treatment apparatus having plastic channels. The interior surface of the plastic channel may be modified to increase the available surface area for interaction with blood monocytes. Platelets and serum protein may be removed from the blood prior to treatment to reduce or eliminate contamination of the plastic channel by these blood components. Functional dendritic cells generated from induced monocytes are incubated together with apoptotic or inactivated disease effector agents to enhance the presentation of at least one disease-causing antigen expressed by the disease effector agents. Compositions including dendritic cells derived from induced monocytes and compositions including such dendritic cells incubated with disease effector agents are also provided for use in immunotherapeutic treatment.

Method For Inducing Selectively Suppressed Immune Response To Transplanted Tissue Or Cells
view source
US Patent:

7625557, Dec 1, 2009
Filed:

Aug 13, 2002
Appl. No.:

10/217856
Inventors:

Richard Leslie Edelson - Westport CT, US
Assignee:

Yale University - New Haven CT
International Classification:

A01N 1/02
A61M 37/00
C12N 5/08
US Classification:

424 937, 424 981, 424 9371, 435 2, 604 401, 604 603, 604 608
Abstract:

Transimmunization methods incorporating skin immunologic challenges are described for either selectively suppressing the immune response of recipients of transplanted tissue or cells or monitoring induced anti-cancer immunity. In one embodiment, skin from the transplant donor is allografted to the transplant recipient to induce an immunological response to the transplanted skin. A quantity of blood is taken from the recipient and treated to render the T cells in the blood apoptotic and to induce differentiation of blood monocytes into dendritic cells. The treated blood is incubated and administered to the recipient to induce formation of suppressor T cell clones which reduce the number of T cells attacking the transplanted tissue or organ. This tolerogenic approach can be complemented by also feeding the immature dendritic cells apoptotic or necrotic cells from the organ donor. In a second embodiment, dendritic cells loaded with tumor antigens are injected intradermally to monitor the anti-cancer immunity induced by Transimmunization.

Method For Suppressing Immune System Response To Transplanted Tissue Or Cells
view source
US Patent:

7727523, Jun 1, 2010
Filed:

Nov 8, 2002
Appl. No.:

10/290802
Inventors:

Richard Leslie Edelson - Westport CT, US
Carole Berger - Bronx NY, US
Michael Girardi - Madison CT, US
Assignee:

Yale University - New Haven CT
International Classification:

A01N 1/02
A61M 37/00
C12N 5/08
US Classification:

424 9371, 424 937, 435 2, 435372, 604 401, 604 603, 604 608
Abstract:

Methods are provided for suppressing the immune system response in recipients of transplanted organs, tissues or cells. An extracorporeal quantity of blood from the intended transplant recipient is treated to induce monocytes contained in the blood to differentiate and form dendritic cells. The maturation of the dendritic cells is truncated at a stage where the dendritic cells can inactivate T cell clones which would otherwise generate an undesired immune system response. The immature dendritic cells can be directly administered to the transplant recipient, or the dendritic cells can be co-incubated with the bone marrow or stem cell preparation, prior to transplantation, in order to suppress or eliminate anti-recipient donor T cells contaminating the bone marrow or stem cell preparation. The methods can be used to suppress graft versus host disease in recipients of transplanted bone marrow or stem cells, or to suppress rejection of transplanted organs or tissue.

Method For Inducing Selectively Suppressed Immune Response To Transplanted Tissue Or Cells
view source
US Patent:

7988951, Aug 2, 2011
Filed:

Nov 30, 2009
Appl. No.:

12/627920
Inventors:

Richard Leslie Edelson - Westport CT, US
Assignee:

Yale University - New Haven CT
International Classification:

A01N 1/02
A61M 37/00
C12N 5/08
US Classification:

424 981, 424 937, 424 9371, 435 2, 604 401, 604 603, 604 608
Abstract:

Transimmunization methods incorporating skin immunologic challenges are described for either selectively suppressing the immune response of recipients of transplanted tissue or cells or monitoring induced anti-cancer immunity. In one embodiment, skin from the transplant donor is allografted to the transplant recipient to induce an immunological response to the transplanted skin. A quantity of blood is taken from the recipient and treated to render the T cells in the blood apoptotic and to induce differentiation of blood monocytes into dendritic cells. The treated blood is incubated and administered to the recipient to induce formation of suppressor T cell clones which reduce the number of T cells attacking the transplanted tissue or organ. This tolerogenic approach can be complemented by also feeding the immature dendritic cells apoptotic or necrotic cells from the organ donor. In a second embodiment, dendritic cells loaded with tumor antigens are injected intradermally to monitor the anti-cancer immunity induced by Transimmunization.

Method For Suppressing Immune System Response To Transplanted Tissue Or Cells
view source
US Patent:

8231868, Jul 31, 2012
Filed:

May 4, 2010
Appl. No.:

12/773141
Inventors:

Richard Leslie Edelson - Westport CT, US
Carole Berger - Bronx NY, US
Michael Girardi - Madison CT, US
Assignee:

Yale University - New Haven CT
International Classification:

A61K 41/00
A61K 35/14
C12N 5/078
C12N 5/0784
US Classification:

424 9371, 435 2, 435372, 435373, 604 401, 604 603, 604 608
Abstract:

Methods are provided for suppressing the immune system response in recipients of transplanted organs, tissues or cells. An extracorporeal quantity of blood from the intended transplant recipient is treated to induce monocytes contained in the blood to differentiate and form dendritic cells. The maturation of the dendritic cells is truncated at a stage where the dendritic cells can inactivate T cell clones which would otherwise generate an undesired immune system response. The immature dendritic cells can be directly administered to the transplant recipient, or the dendritic cells can be co-incubated with the bone marrow or stem cell preparation, prior to transplantation, in order to suppress or eliminate anti-recipient donor T cells contaminating the bone marrow or stem cell preparation. The methods can be used to suppress graft versus host disease in recipients of transplanted bone marrow or stem cells, or to suppress rejection of transplanted organs or tissue.